Quipt Home Medical Corp. (QIPT)
Mar 16, 2026 - QIPT was delisted
3.650
0.00 (0.00%)
Inactive · Last trade price on Mar 13, 2026
Quipt Home Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 12, 2026 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| 159 | 169 | 293 | 203 | 264 | 588 | |
Market Cap Growth | 37.77% | -42.13% | 44.18% | -23.16% | -55.11% | 107.01% |
Enterprise Value | 263.65 | 231.03 | 350.78 | 209.36 | 236.85 | 566.37 |
Last Close Price | 3.65 | 3.93 | 6.95 | 5.70 | 7.92 | 5.24 |
Price Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 12, 2026 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
PE Ratio | - | - | - | 31.69 | - | - |
PS Ratio | 0.60 | 0.69 | 1.38 | 1.45 | 2.58 | 8.10 |
PB Ratio | 1.40 | 1.58 | 2.63 | 2.55 | - | - |
P/FCF Ratio | 5.96 | 6.76 | 9.71 | 11.81 | 20.77 | 42.20 |
P/OCF Ratio | 4.25 | 4.79 | 7.91 | 7.70 | 14.87 | 41.92 |
EV Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 12, 2026 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
EV/Sales Ratio | 1.00 | 0.94 | 1.66 | 1.50 | 2.31 | 7.80 |
EV/EBITDA Ratio | 6.05 | 5.06 | 9.01 | 7.54 | 14.51 | 37.26 |
EV/EBIT Ratio | - | 207.20 | 122.95 | 44.25 | - | 860.74 |
EV/FCF Ratio | 9.92 | 9.22 | 11.64 | 12.18 | 18.63 | 40.62 |
Financial Efficiency
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 12, 2026 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Debt / Equity Ratio | 0.71 | 0.73 | 0.68 | 0.19 | 0 | 0 |
Debt / EBITDA Ratio | 2.48 | 2.18 | 2.52 | 0.96 | - | - |
Debt / FCF Ratio | 3.83 | 3.98 | 3.25 | 1.55 | - | - |
Net Debt / Equity Ratio | 0.79 | 0.78 | 0.73 | 0.23 | - | - |
Net Debt / EBITDA Ratio | 2.18 | 1.83 | 2.07 | 0.65 | -1.67 | -1.44 |
Net Debt / FCF Ratio | 3.36 | 3.34 | 2.68 | 1.05 | -2.15 | -1.57 |
Asset Turnover | 0.96 | 0.99 | 1.12 | 1.28 | 1.46 | 1.52 |
Inventory Turnover | 2.97 | 3.48 | 3.37 | 4.26 | - | 5.57 |
Quick Ratio | 0.64 | 0.68 | 0.71 | 0.66 | 1.75 | 1.86 |
Current Ratio | 1.15 | 1.20 | 1.08 | 1.10 | 1.75 | 1.86 |
Return on Equity (ROE) | -9.83% | -6.20% | -2.92% | 7.70% | -18.31% | -20.76% |
Return on Assets (ROA) | -1.71% | 0.46% | 1.55% | 7.16% | -1.38% | 1.42% |
Return on Invested Capital (ROIC) | -2.14% | 0.58% | 1.93% | 11.23% | -4.17% | 4.54% |
Return on Capital Employed (ROCE) | -2.33% | 0.60% | 2.03% | 6.13% | -3.05% | 2.08% |
Yields
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 12, 2026 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Earnings Yield | - | - | - | 3.16% | - | - |
FCF Yield | 16.77% | 14.80% | 10.30% | 8.47% | 4.81% | 2.37% |
Buyback Yield / Dilution | -1.57% | -10.09% | -6.35% | -19.27% | -33.96% | - |
Total Shareholder Return | -1.57% | -10.09% | -6.35% | -19.27% | -33.96% | - |